BioSpace News Archive

Amphastar Pharmaceuticals, Inc. announced that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulatory Affairs and Clinical Operations will be presenting at BMO Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020 at 1:00 p.m. Eastern Time.

The Tuberous Sclerosis Alliance and Seizure Tracker™ announced a partnership to promote data sharing and biosample collection from people with tuberous sclerosis complex, a rare genetic condition that causes tumors to form in vital organs.

Pharmaceutical companies in the G-protein coupled receptors market are tapping into the advances in the biology of GPCR in the pursuit of new, novel drug targets.

An emergency aid or treatment given to an individual who is injured or affected with a sudden illness, before the arrival of regular medical services can be termed as first aid.

The technique or procedure used to deliver drugs or pharmaceuticals to a targeted site with the aim of curative solution is called as drug delivery.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that the United States Patent and Trademark Office has granted a patent covering its proprietary platform technology for the oral administration of Foralumab, its proprietary fully human monoclonal antibody, and all other anti-CD3 monoclonal antibodies.

Dr. Reddy’s Laboratories Ltd. announced the launch of Abiraterone Acetate Tablets USP, 250 mg, a therapeutic equivalent generic version of Zytiga® approved by the U.S. Food and Drug Administration.

MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce its participation at upcoming virtual investor conferences.

Obalon Therapeutics, Inc., a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announced its financial results for the first quarter ended March 31, 2020 and provided a business update.

Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, announced the successful completion of a $50 million Series C financing.